Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
- 19 April 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Psychiatry
- Vol. 16 (11), 1068-1070
- https://doi.org/10.1038/mp.2011.47
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA AntagonistsScience, 2010
- Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?Neuropsychopharmacology, 2010
- Ketamine and the next generation of antidepressants with a rapid onset of actionPharmacology & Therapeutics, 2009
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid ReceptorsBiological Psychiatry, 2007
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major DepressionArchives of General Psychiatry, 2006
- In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptorsNeurobiology of Aging, 2006
- Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysisThe EMBO Journal, 2005
- The glamour and gloom of glycogen synthase kinase-3Trends in Biochemical Sciences, 2004
- Antidepressant effects of ketamine in depressed patientsBiological Psychiatry, 2000
- A molecular mechanism for the effect of lithium on development.Proceedings of the National Academy of Sciences of the United States of America, 1996